Integration of mechanism-based in vitro methods and quantitative in vitro-in vivo extrapolation (QIVIVE) modelling for prediction of nephrotoxicity

被引：0
|
作者：
Mally, A. [1 ]
Birk, B. [2 ]
DiFiore, S. [3 ]
Ellinger, B. [4 ]
Jarzina, S. [1 ]
Taverne, F. [5 ]
Kramer, N. [5 ]
机构：
[1] Univ Wurzburg, Dept Toxicol, Wurzburg, Germany
[2] BASF, Expt Toxicol & Ecol, Ludwigshafen, Germany
[3] Fraunhofer Inst Mol Biol & Appl Ecol, Div Mol Biotechnol, Aachen, Germany
[4] Fraunhofer Inst Mol Biol & Appl Ecol, Div Translat Med, Hamburg, Germany
[5] Univ Utrecht, Inst Risk Assessment Sci, Toxicol Div, Utrecht, Netherlands
来源：
TOXICOLOGY LETTERS | 2018年 / 295卷
关键词：
D O I：
10.1016/j.toxlet.2018.06.1123
中图分类号：
R99 [毒物学（毒理学）];
学科分类号：
100405 ;
摘要：
S08-02
引用
收藏
页码：S27 / S27
页数：1
相关论文
共 50 条
  • [41] PREDICTION OF DRUG CLEARANCE IN GENENTECH: A RETROSPECTIVE ANALYSIS OF IN VITRO IN VIVO EXTRAPOLATION METHODS AND ALLOMETRY METHODS
    Mao, Jialin
    Chen, Yuan
    Fan, Peter
    Kenny, Jane
    Liederer, Bianca M.
    Liu, Xingrong
    Wright, Matthew
    Hop, Cornelis E. C. A.
    DRUG METABOLISM REVIEWS, 2015, 47 : 51 - 52
  • [42] Interpretation of Non-Clinical Data for Prediction of Human Pharmacokinetic Parameters: In Vitro-In Vivo Extrapolation and Allometric Scaling
    Choi, Go-Wun
    Lee, Yong-Bok
    Cho, Hea-Young
    PHARMACEUTICS, 2019, 11 (04):
  • [43] A 20-Year Research Overview: Quantitative Prediction of Hepatic Clearance Using the In Vitro-In Vivo Extrapolation Approach Based on Physiologically Based Pharmacokinetic Modeling and Extended Clearance Concept
    Sugiyama, Yuichi
    Aoki, Yasunori
    DRUG METABOLISM AND DISPOSITION, 2023, 51 (09) : 1067 - 1076
  • [44] Quantitative in vitro to in vivo extrapolation of cell-based toxicity assay results
    Yoon, Miyoung
    Campbell, Jerry L.
    Andersen, Melvin E.
    Clewell, Harvey J.
    CRITICAL REVIEWS IN TOXICOLOGY, 2012, 42 (08) : 633 - 652
  • [45] Predictive performance of physiologically based kinetic (PBK) models based on in-silico/in vitro-in vivo extrapolation (IS/IVIVE)
    Kalra, P.
    Zhou, H.
    Lawless, M.
    TOXICOLOGY LETTERS, 2023, 384 : S259 - S260
  • [46] In Vitro-In Vivo Extrapolation by Physiologically Based Kinetic Modeling: Experience With Three Case Studies and Lessons Learned
    Algharably, Engi Abdelhady
    Di Consiglio, Emma
    Testai, Emanuela
    Pistollato, Francesca
    Mielke, Hans
    Gundert-Remy, Ursula
    FRONTIERS IN TOXICOLOGY, 2022, 4
  • [47] Physiologically Based Pharmacokinetics Joined With In Vitro-In Vivo Extrapolation of ADME: A Marriage Under the Arch of Systems Pharmacology
    Rostami-Hodjegan, A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 92 (01) : 50 - 61
  • [48] Prediction of CYP Down Regulation after Tusamitamab Ravtansine Administration (a DM4-Conjugate), Based on an In Vitro-In Vivo Extrapolation Approach
    Pouzin, Clemence
    Teutonico, Donato
    Fagniez, Nathalie
    Ziti-Ljajic, Samira
    Perreard-Dumaine, Anne
    Pardon, Magalie
    Klieber, Sylvie
    Nguyen, Laurent
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 115 (02) : 278 - 287
  • [49] Analysis of Time-Dependent Pharmacokinetics Using In Vitro-In Vivo Extrapolation and Physiologically Based Pharmacokinetic Modeling
    Kim, Min-Chang
    Lee, Young-Joo
    PHARMACEUTICS, 2022, 14 (12)
  • [50] In vitro Methods for In vitro-In vivo Correlation (IVIVC) for Poorly Water Soluble Drugs: Lipid Based Formulation Perspective
    Kazi, Mohsin
    Al Amri, Rayan
    Alanazi, Fars K.
    Hussain, Muhammad Delwar
    CURRENT DRUG DELIVERY, 2018, 15 (07) : 918 - 929
12345